US 7264799
Use of heparinases to decrease inflammatory response
granted A61KA61K38/51A61K47/50
Quick answer
US patent 7264799 (Use of heparinases to decrease inflammatory response) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/51, A61K47/50, A61P, A61P29/00